熱門資訊> 正文

阿尔托神经科学GAAP每股收益为-0.52美元

2025-11-12 22:56

Invesco Actively Managed Exchange-Traded Fund Trust Invesco SteelPath MLP & Energy Infrastructure ETF(PIPE) 0

Alto Neuroscience press release (ANRO): Q3 GAAP EPS of -$0.52.
As of September 30, 2025, the Company had cash, cash equivalents, and restricted cash of approximately $138.3 million, compared to approximately $168.7 million in cash, cash equivalents, and restricted cash as of December 31, 2024.

More on Alto Neuroscience

Alto Neuroscience secures $50M in PIPE financing
Seeking Alpha’s Quant Rating on Alto Neuroscience
Historical earnings data for Alto Neuroscience
Financial information for Alto Neuroscience

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。